Michael Eissenstat
Rensselaer Polytechnic Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Eissenstat.
Bioorganic & Medicinal Chemistry Letters | 1996
Thomas E. D'Ambra; Michael Eissenstat; Jeffrey W. Abt; James H. Ackerman; Edward R. Bacon; Malcolm R. Bell; Philip M. Carabateas; Kurt A. Josef; Virendra Kumar; John D. Weaver; Renee Arnold; Frances M. Casiano; Susan M. Chippari; Dean A. Haycock; Joan E. Kuster; Daniel Luttinger; Joan I. Stevenson; Susan Jean Ward; W.Adam G. Hill; Atmaram D. Khanolkar; Alexandros Makriyannis
Abstract Aminoalkylindoles (AAIs) with potent cannabinoid agonist activity have been synthesized where the aminoalkyl chain is attached to the indole ring via a carbon atom of the cyclic amine.
Bioorganic & Medicinal Chemistry Letters | 1995
Virendra Kumar; Michael D. Alexander; Malcolm R. Bell; Michael Eissenstat; Frances M. Casiano; Susan M. Chippari; Dean A. Haycock; Daniel Luttinger; Joan E. Kuster; Matthew S. Miller; Joan I. Stevenson; Susan Jean Ward
Abstract Indence analogs of pravadoline exhibited antinociceptive activity in several animal models. The inhibition of prostaglandin (PG) synthesis in mouse brain microsomes was diminished in these pravadoline analogs, but they were potent in inhibiting electrically stimulated contractions in the mouse vas deferens (MVD) preparations. Binding studies with ligand WIN 55212-2 have aided to demonstrate that the morpholinoalkyl-indene binding site is functionally equivalent with cannabinoid binding site. The antinociceptive activity of the indene derivatives appears to be mediated by increased affinity for the cannabinoid receptor.
Bioorganic & Medicinal Chemistry Letters | 1995
Michael Eissenstat; Gee-Hong Kuo; John D. Weaver; Mark P. Wentland; Ronald G. Robinson; Kristina M. Klingbeil; Deborah W. Danz; Thomas H. Corbett; Susan A. Coughlin
Abstract Replacement of the 3-carboxy group of quinolone topoisomerase II inhibitors by hydroxy substituted benzyl groups resulted in potent topoisomerase II inhibitors. The 2,6-dihydroxybenzyl analog, Win 64593, had a topo II EC 50 of 96 nM and had potent in vitro cytotoxicity as well as murine antitumor activity.
Proteases of Infectious Agents | 1999
John W. Erickson; Michael Eissenstat
Publisher Summary This chapter discusses the key biological and structural features of HIV protease (HIV PR) that define its usefulness as an antiviral target. HIV proteases have proven to be valuable instructional targets for the design of mechanism- and structure-based drugs, and for providing novel strategies for designing antiviral therapeutics. The introduction of PR inhibitors to the armamentarium of AIDS drugs has had a profoundly successful impact on the AIDS community where these drugs are prolonging life and providing new hope for the long-term maintenance of relatively good health until such time as a more effective cure or vaccine becomes available. The chapter presents a brief review as well as an update on efforts to discover and design inhibitors of HIV PR inhibitors. The problem of drug resistance to HIV PR inhibitors is discussed with an emphasis on viral strategies for resistance and on implications for future drug discovery efforts in this area.
Tetrahedron Letters | 1994
Michael Reuman; Michael Eissenstat; John D. Weaver
Abstract Electron deficient 3-quinolinecarboxylic acids undergo ready decarboxylation in the presence of cyanide ion. This reaction most likely requires the addition of CN − to the 2-position of the quinoline (or naphthyridine) nucleus to provide a β-keto acid intermediate that rapidly decarboxylates to give the 3-H substituted product.
Bioorganic & Medicinal Chemistry Letters | 1995
Gee-Hong Kuo; Michael Eissenstat; Mark P. Wentland; Ron G. Robinson; Kristina M. Klingbeil; Debbie W. Danz; Susan A. Coughlin
A series of novel 4-substituted-1,4-dihydro-quinolines 3 were prepared and found to exhibit moderate to excellent mammalian topo II inhibitory activity. Among the compounds prepared, in general, the nitrogen analogues are the most active compounds and the sulfur analogue is the least active one.
Tetrahedron Letters | 1995
Michael Eissenstat; John D. Weaver
Abstract Transfer of a sulfonyl group from an indole nitrogen to a β-amino alkoxide generates an indole anion and an aminoethylsulfonate which react to give aminoethylindoles.
Bioorganic & Medicinal Chemistry Letters | 1993
Mark P. Wentland; George Y. Lesher; Michael Reuman; Garry M. Pilling; Manohar T. Saindane; Robert B. Perni; Michael Eissenstat; John D. Weaver; Baldev Singh; James B. Rake; Susan A. Coughlin
Abstract Several enantiomerically pure (2,6-dimethyl-4-pyridinyl)quinolones, previously shown to be potent inhibitors of bacterial DNA gyrase, exhibit topoisomerase II inhibitory activity. Among these and other analogues, topoisomerase II inhibitory potency was found to be a sensitive function of the size and substitution of the bridge spanning the 1- and 8-positions of the quinoline ring. The 6-fluoro group was required for activity.
Tetrahedron Letters | 1997
Gee-Hong Kuo; Michael Eissenstat
Abstract Several 2-methyl-4-substituted phenols 5 were oxidatively rearranged to 1,2-(methylenedioxy)-4-substituted benzenes 6 in the presence of base and air. A mechanism was proposed.
Journal of Medicinal Chemistry | 1992
Thomas E. D'Ambra; Estep Kg; Malcolm R. Bell; Michael Eissenstat; Josef Ka; Susan Jean Ward; Haycock Da; Baizman Er; Casiano Fm; Beglin Nc